Back to results
US 2019/0292267 A1Published application
Bispecific cxcr4-cd4 polypeptides with potent anti-hiv activity
AssigneeAblynx N.V.
InventorsHugo Soares, Dominique Schols, Peter Vanlandschoot, Philippe Van Rompaey, Catelijne Stortelers
Life of this patent
Estimating the term…
Abstract
The present invention relates to bispecific polypeptides that are directed against the cellular receptor CD4 as well as a cellular co-receptor for HIV. Said polypeptides may be used to prevent human cell entry of HIV.
Claims17
Polypeptide comprising a first and a second immunoglobulin single variable domain (ISV), wherein
- said first ISV binds to CD4 present on the surface of a cell;
- and
- said second ISV binds to CXCR4 present on the surface of said cell.
(canceled)
Dependencies are inferred from the claim text.